Evidence map›Paper›PMID 31074406›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Seroepidemiology of Hepatitis B in the Democratic Republic of the Congo.

Peyton Thompson, Jonathan B Parr, Vera Holzmayer, Margaret Carrel, Antoinette Tshefu, Kashamuka Mwandagalirwa, Jérémie Muwonga, Placide O Welo, Franck Fwamba, Mary Kuhns and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Peyton ThompsonDivision of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.
Jonathan B ParrDivision of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Vera HolzmayerAbbott Laboratories, Abbott Park, Illinois.
Margaret CarrelDepartment of Geographical and Sustainability Sciences, University of Iowa, Iowa City, Iowa.
Antoinette TshefuKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Kashamuka MwandagalirwaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Jérémie MuwongaNational AIDS Control Program, Kinshasa, Democratic Republic of the Congo.
Placide O WeloNational AIDS Control Program, Kinshasa, Democratic Republic of the Congo.
Franck FwambaNational AIDS Control Program, Kinshasa, Democratic Republic of the Congo.
Mary KuhnsAbbott Laboratories, Abbott Park, Illinois.
Ravi JhaveriDivision of Infectious Diseases, Department of Pediatrics, Northwestern University, Evanston, Illinois.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
Gavin ClohertyAbbott Laboratories, Abbott Park, Illinois.
Abbott Fund · USUniversity of North Carolina at Chapel Hill · USMinistry of Public Health · CDNorthwestern University · USUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) is endemic throughout Africa, but its prevalence in the Democratic Republic of the Congo (DRC) is incompletely understood. We used dried blood spot (DBS) samples from the 2013 to 2014 Demographic and Health Survey in the DRC to measure the prevalence of HBV using the Abbott ARCHITECT HBV surface antigen (HBsAg) qualitative assay. We then attempted to sequence and genotype HBsAg-positive samples. The weighted national prevalence of HBV was 3.3% (95% CI: 1.8-4.7%), with a prevalence of 2.2% (95% CI: 0.3-4.1%) among children. Hepatitis B virus cases occurred countrywide and across age strata. Genotype E predominated (60%), and we found a unique cluster of genotype A isolates (30%). In conclusion, DBS-based HBsAg testing from a nationally representative survey found that HBV is common and widely distributed among Congolese adults and children. The distribution of cases across ages suggests ongoing transmission and underscores the need for additional interventions to prevent HBV infection.

Indexed as

AdolescentAdultChildChild, PreschoolDemocratic Republic of the CongoFemaleGenotyping TechniquesHepatitis BHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansInfantMalePrevalenceSeroepidemiologic StudiesHepatitis B Surface AntigensHepatitis B Vaccines

Identifiers

PMID31074406
PMCPMC6609197
OpenAlexW2944046888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.